Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin for severe infection in solid organ transplant recipients with post-transplant IgG hypogammaglobulinemia
2012-001327-12Phase 2Active
- Sponsor
- Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of immune globulin in hypogammaglobulinemia and Infection (2 arms), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoint: Incidence and cumulative incidence of severe infections. Started Sep 2012; status: active.
02
Drugs
immune globulin
03
Conditions
hypogammaglobulinemiaInfection
Beyond the preview
Go deeper on 2012-001327-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001327-12.